Fairvalue-Calculator Fairvalue-Calculator
EN DE

Hydromer, Inc (HYDI) Fair Value & Analysis

Basic Materials · US · Market cap $716K

Price$0.2200
Fair Value$1.19
Upside+440.9%
Quality89/100
Evidence: Low Range $0.8900 – $1.48

Fair value as of: Jun 23, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Hydromer, Inc (HYDI) currently trades at $0.2200, while our model-based Fair Value estimate is $1.19 — implying the stock looks roughly 440.9% undervalued today. We read business quality at 89/100 (high quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Hydromer, Inc. invents, develops, patents, licenses, manufactures, and sells hydrophilic polymer-based products and services in the United States and internationally. The company operates in two segments, Polymer Research and Medical Products. It offers medical coatings and services; medical hydrogel; cosmetic intermediaries; and anti-fog/anti-frost condensation control coating products. The company also provides cosmetics and personal care products, and watercraft hulls coating products; and engineering and contract coating services. It serves the medical, cosmetics, animal health, and industrial fields. Hydromer, Inc. was founded in 1980 and is based in Branchburg, New Jersey.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Hydromer, Inc (HYDI) undervalued?
As of Jun 23, 2026, our model estimates a fair value of $1.19 versus a price of $0.2200 — about +441% (undervalued). Model-based estimate, not financial advice.
What is the fair value of HYDI?
Our 21-model fair value for Hydromer, Inc is $1.19 (as of Jun 23, 2026), built from audited fundamentals. The current price is $0.2200.
What is the quality score of HYDI?
Hydromer, Inc has a Quality Score of 89/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.